カテゴリ： Allied Market Research, 世界, 医療/バイオ

マイクロバイオームシーケンスのグローバル市場（2021〜2031）：ショットガンシーケンス、RNAシーケンス、標的遺伝子シーケンス、全ゲノムシーケンス、その他

■ 英語タイトル：Microbiome Sequencing Market By Technique (Shotgun sequencing, RNA sequencing, Targeted gene sequencing, Whole genome sequencing, Others), By Research (Outsourced, Internal), By End user (Pharmaceutical and biotechnological companies, Academic institutes and research centers): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23MA110）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23MA110
■ 発行日：2022年12月
■ 調査対象地域：グローバル
■ 産業分野：バイオ
■ ページ数：235
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[マイクロバイオームシーケンスのグローバル市場（2021〜2031）：ショットガンシーケンス、RNAシーケンス、標的遺伝子シーケンス、全ゲノムシーケンス、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本調査レポートによると、2021年に859.42百万ドルであった世界のマイクロバイオームシーケンス市場規模が、2031年までに3,417.09百万ドルに達し、2022年から2031年の間に年平均14.8%で成長すると予測されています。本書は、マイクロバイオームシーケンスの世界市場について調査し、市場動向や今後の展望をまとめた資料です。イントロダクション、エグゼクティブサマリー、市場概要、技術別（ショットガンシーケンス、RNAシーケンス、標的遺伝子シーケンス、全ゲノムシーケンス、その他）分析、研究別（アウトソーシング、インターナル）分析、エンドユーザー別（製薬・バイオテクノロジー企業、学術機関・研究機関）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況、企業情報など、以下の構成で掲載しています。本書内には、Microbiome Insights、 Clinical Microbiomics、Baseclear BV、CosmosID、 Novogene Co., Ltd. 、Zymo Research Corporation、Resphera Biosciences, LLC、OraSure Technologies (Diversigen)、Molecular Research LP、Charles River Laboratories International, Inc.など、主な参入企業情報が含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界のマイクロバイオームシーケンス市場規模：技術別
- ショットガンシーケンスの市場規模
- RNAシーケンスの市場規模
- 標的遺伝子シーケンスの市場規模
- 全ゲノムシーケンスの市場規模
- その他の市場規模
・世界のマイクロバイオームシーケンス市場規模：研究別
- アウトソーシングにおける市場規模
- インターナルにおける市場規模
・世界のマイクロバイオームシーケンス市場規模：エンドユーザー別
- 製薬・バイオテクノロジー企業における市場規模
- 学術機関・研究機関における市場規模
・世界のマイクロバイオームシーケンス市場規模：地域別
- 北米のマイクロバイオームシーケンス市場規模
- ヨーロッパのマイクロバイオームシーケンス市場規模
- アジア太平洋のマイクロバイオームシーケンス市場規模
- 中南米・中東・アフリカのマイクロバイオームシーケンス市場規模
・競争状況
・企業情報

マイクロバイオームシーケンス市場規模は、2021年に8億5,942万ドルと評価され、2022年から2031年にかけて14.8%のCAGRを示し、2031年には34億1,709万ドルに達すると予測されています。
マイクロバイオームシーケンスは、サンプル内のすべての細菌、ウイルス、真菌、原生生物の遺伝物質を解読するために使用される技術です。また、マイクロバイオームが特定の微生物群集の構造と機能を明らかにする鍵となるため、微生物のシーケンシングは不可欠です。細菌ゲノムの配列決定により、細菌の系統学および分類学の理解が著しく向上しました。微生物のシーケンシングにより、標的ゲノム内の変異を検出し、サンプル中に存在する細菌、ウイルス、真菌、原生生物の遺伝物質を解釈することができます。

マイクロバイオームシーケンス市場の推進要因は、疾患の早期診断におけるマイクロバイオームシーケンスの使用と、さまざまな疾患に対する個別化医薬品の開発におけるこの技術の活用です。例えば、Frontiers in Cellular and Infection Microbiology 2021に掲載された論文によると、膵臓がん患者のマイクロバイオームの理解とその操作は、膵臓がんの診断と治療に役立ちます。さらに、個別化医療と呼ばれる新たな治療アプローチが医学に新たな窓を開き、市場の成長を後押ししています。マイクロバイオームと個別化医療との関連は、その後の研究で最も興味深い側面の1つであり、がんや感染症などの疾患の治療に極めて重要な視点を持っています。また、ゲノミクス、プロテオミクス、メタボロミクスにおけるマイクロバイオーム・シーケンスの利用の増加が市場の成長を促進すると予想されます。
しかし、マイクロバイオームシーケンスの運用システムの熟練者が不足しているなどの要因が、マイクロバイオームシーケンス市場の成長を抑制しています。さらに、マイクロバイオームシーケンスに関する政府による厳しい規則や規制も、市場の成長を阻害する可能性があります。

マイクロバイオームシーケンス市場は、技術、研究、エンドユーザー、地域に区分されます。技術別では、市場はショットガンシーケンス、RNAシーケンス、標的遺伝子シーケンス、全ゲノムシーケンス、その他に分類されます。研究別では、市場は外部委託と内部委託に分別されます。エンドユーザー別では、市場は製薬・バイオテクノロジー企業と学術機関・研究センターに分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他欧州）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、その他アジア太平洋）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他LAMEA）に市場を分けて分析します。

世界のマイクロバイオームシーケンス市場で事業を展開する主な企業は、Baseclear BV、Charles River Laboratories International, Inc.、Clinical Microbiomics、CosmosID、Microbiome Insights、Molecular Research LP、Novogene Co.Ltd.、OraSure Technologies（Diversigen）、Resphera Biosciences Llc、Zymo Research Corporationです。

ステークホルダーにとっての主な利点
・本レポートは、2021年から2031年までのマイクロバイオームシーケンス市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、優勢なマイクロバイオームシーケンス市場機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・マイクロバイオームシーケンス市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界のマイクロバイオームシーケンス市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
技術別
ショットガンシーケンス
RNAシーケンス
ターゲット遺伝子シーケンス
全ゲノムシーケンス
その他

研究別
外部委託
社内

エンドユーザー別
製薬・バイオテクノロジー企業
学術機関・研究所

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
イギリス
フランス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Microbiome Insights
Clinical Microbiomics
Baseclear BV
CosmosID
Novogene Co., Ltd.
Zymo Research Corporation
Resphera Biosciences, LLC
OraSure Technologies (Diversigen)
Molecular Research LP
Charles River Laboratories International, Inc.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1. Rise in investment in microbiome research
3.4.1.2. Use of microbiome in diagnosis of diseases
3.4.1.3. Increase in collaborations and partnerships for microbiome research

3.4.2.Restraints
3.4.2.1. Ethical and legal limitations

3.4.3.Opportunities
3.4.3.1. Wide applications of microbiome research

3.5.COVID-19 Impact Analysis on the market
CHAPTER 4: MICROBIOME SEQUENCING MARKET, BY TECHNIQUE
4.1 Overview
4.1.1 Market size and forecast
4.2. Shotgun sequencing
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. RNA sequencing
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4. Targeted gene sequencing
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
4.5. Whole genome sequencing
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market share analysis by country
4.6. Others
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market share analysis by country
CHAPTER 5: MICROBIOME SEQUENCING MARKET, BY RESEARCH
5.1 Overview
5.1.1 Market size and forecast
5.2. Outsourced
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. Internal
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: MICROBIOME SEQUENCING MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2. Pharmaceutical and biotechnological companies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3. Academic institutes and research centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
CHAPTER 7: MICROBIOME SEQUENCING MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Technique
7.2.3 North America Market size and forecast, by Research
7.2.4 North America Market size and forecast, by End user
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Technique
7.2.5.1.3 Market size and forecast, by Research
7.2.5.1.4 Market size and forecast, by End user
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Technique
7.2.5.2.3 Market size and forecast, by Research
7.2.5.2.4 Market size and forecast, by End user
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Technique
7.2.5.3.3 Market size and forecast, by Research
7.2.5.3.4 Market size and forecast, by End user
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Technique
7.3.3 Europe Market size and forecast, by Research
7.3.4 Europe Market size and forecast, by End user
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Technique
7.3.5.1.3 Market size and forecast, by Research
7.3.5.1.4 Market size and forecast, by End user
7.3.5.2 UK
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Technique
7.3.5.2.3 Market size and forecast, by Research
7.3.5.2.4 Market size and forecast, by End user
7.3.5.3 France
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Technique
7.3.5.3.3 Market size and forecast, by Research
7.3.5.3.4 Market size and forecast, by End user
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Technique
7.3.5.4.3 Market size and forecast, by Research
7.3.5.4.4 Market size and forecast, by End user
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Technique
7.3.5.5.3 Market size and forecast, by Research
7.3.5.5.4 Market size and forecast, by End user
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Technique
7.3.5.6.3 Market size and forecast, by Research
7.3.5.6.4 Market size and forecast, by End user
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Technique
7.4.3 Asia-Pacific Market size and forecast, by Research
7.4.4 Asia-Pacific Market size and forecast, by End user
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Technique
7.4.5.1.3 Market size and forecast, by Research
7.4.5.1.4 Market size and forecast, by End user
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Technique
7.4.5.2.3 Market size and forecast, by Research
7.4.5.2.4 Market size and forecast, by End user
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Technique
7.4.5.3.3 Market size and forecast, by Research
7.4.5.3.4 Market size and forecast, by End user
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Technique
7.4.5.4.3 Market size and forecast, by Research
7.4.5.4.4 Market size and forecast, by End user
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Technique
7.4.5.5.3 Market size and forecast, by Research
7.4.5.5.4 Market size and forecast, by End user
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Technique
7.4.5.6.3 Market size and forecast, by Research
7.4.5.6.4 Market size and forecast, by End user
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Technique
7.5.3 LAMEA Market size and forecast, by Research
7.5.4 LAMEA Market size and forecast, by End user
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Technique
7.5.5.1.3 Market size and forecast, by Research
7.5.5.1.4 Market size and forecast, by End user
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Technique
7.5.5.2.3 Market size and forecast, by Research
7.5.5.2.4 Market size and forecast, by End user
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Technique
7.5.5.3.3 Market size and forecast, by Research
7.5.5.3.4 Market size and forecast, by End user
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Technique
7.5.5.4.3 Market size and forecast, by Research
7.5.5.4.4 Market size and forecast, by End user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1 Microbiome Insights
9.1.1 Company overview
9.1.2 Key Executives
9.1.3 Company snapshot
9.1.4 Operating business segments
9.1.5 Product portfolio
9.1.6 Business performance
9.1.7 Key strategic moves and developments
9.2  Clinical Microbiomics
9.2.1 Company overview
9.2.2 Key Executives
9.2.3 Company snapshot
9.2.4 Operating business segments
9.2.5 Product portfolio
9.2.6 Business performance
9.2.7 Key strategic moves and developments
9.3 Baseclear BV
9.3.1 Company overview
9.3.2 Key Executives
9.3.3 Company snapshot
9.3.4 Operating business segments
9.3.5 Product portfolio
9.3.6 Business performance
9.3.7 Key strategic moves and developments
9.4 CosmosID
9.4.1 Company overview
9.4.2 Key Executives
9.4.3 Company snapshot
9.4.4 Operating business segments
9.4.5 Product portfolio
9.4.6 Business performance
9.4.7 Key strategic moves and developments
9.5  Novogene Co., Ltd.
9.5.1 Company overview
9.5.2 Key Executives
9.5.3 Company snapshot
9.5.4 Operating business segments
9.5.5 Product portfolio
9.5.6 Business performance
9.5.7 Key strategic moves and developments
9.6 Zymo Research Corporation
9.6.1 Company overview
9.6.2 Key Executives
9.6.3 Company snapshot
9.6.4 Operating business segments
9.6.5 Product portfolio
9.6.6 Business performance
9.6.7 Key strategic moves and developments
9.7 Resphera Biosciences, LLC
9.7.1 Company overview
9.7.2 Key Executives
9.7.3 Company snapshot
9.7.4 Operating business segments
9.7.5 Product portfolio
9.7.6 Business performance
9.7.7 Key strategic moves and developments
9.8 OraSure Technologies (Diversigen)
9.8.1 Company overview
9.8.2 Key Executives
9.8.3 Company snapshot
9.8.4 Operating business segments
9.8.5 Product portfolio
9.8.6 Business performance
9.8.7 Key strategic moves and developments
9.9 Molecular Research LP
9.9.1 Company overview
9.9.2 Key Executives
9.9.3 Company snapshot
9.9.4 Operating business segments
9.9.5 Product portfolio
9.9.6 Business performance
9.9.7 Key strategic moves and developments
9.10 Charles River Laboratories International, Inc.
9.10.1 Company overview
9.10.2 Key Executives
9.10.3 Company snapshot
9.10.4 Operating business segments
9.10.5 Product portfolio
9.10.6 Business performance
9.10.7 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. MICROBIOME SEQUENCING MARKET FOR SHOTGUN SEQUENCING, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. MICROBIOME SEQUENCING MARKET FOR RNA SEQUENCING, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 4. MICROBIOME SEQUENCING MARKET FOR TARGETED GENE SEQUENCING, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. MICROBIOME SEQUENCING MARKET FOR WHOLE GENOME SEQUENCING, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 6. MICROBIOME SEQUENCING MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 7. GLOBAL MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 8. MICROBIOME SEQUENCING MARKET FOR OUTSOURCED, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 9. MICROBIOME SEQUENCING MARKET FOR INTERNAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. GLOBAL MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 11. MICROBIOME SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. MICROBIOME SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. MICROBIOME SEQUENCING MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 14. NORTH AMERICA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 15. NORTH AMERICA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 16. NORTH AMERICA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 17. NORTH AMERICA MICROBIOME SEQUENCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 18. U.S. MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 19. U.S. MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 20. U.S. MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 21. CANADA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 22. CANADA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 23. CANADA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 24. MEXICO MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 25. MEXICO MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 26. MEXICO MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 27. EUROPE MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 28. EUROPE MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 29. EUROPE MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 30. EUROPE MICROBIOME SEQUENCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 31. GERMANY MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 32. GERMANY MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 33. GERMANY MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 34. UK MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 35. UK MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 36. UK MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 37. FRANCE MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 38. FRANCE MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 39. FRANCE MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 40. ITALY MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 41. ITALY MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 42. ITALY MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 43. SPAIN MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 44. SPAIN MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 45. SPAIN MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 46. REST OF EUROPE MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 47. REST OF EUROPE MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 48. REST OF EUROPE MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 49. ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 50. ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 51. ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 52. ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 53. JAPAN MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 54. JAPAN MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 55. JAPAN MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 56. CHINA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 57. CHINA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 58. CHINA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 59. INDIA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 60. INDIA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 61. INDIA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 62. AUSTRALIA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 63. AUSTRALIA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 64. AUSTRALIA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 65. SOUTH KOREA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 66. SOUTH KOREA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 67. SOUTH KOREA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 68. REST OF ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 69. REST OF ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 70. REST OF ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 71. LAMEA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 72. LAMEA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 73. LAMEA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 74. LAMEA MICROBIOME SEQUENCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 75. BRAZIL MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 76. BRAZIL MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 77. BRAZIL MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 78. SAUDI ARABIA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 79. SAUDI ARABIA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 80. SAUDI ARABIA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 81. SOUTH AFRICA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 82. SOUTH AFRICA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 83. SOUTH AFRICA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 84. REST OF LAMEA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION)
TABLE 85. REST OF LAMEA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION)
TABLE 86. REST OF LAMEA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 87. MICROBIOME INSIGHTS: KEY EXECUTIVES
TABLE 88. MICROBIOME INSIGHTS: COMPANY SNAPSHOT
TABLE 89. MICROBIOME INSIGHTS: OPERATING SEGMENTS
TABLE 90. MICROBIOME INSIGHTS: PRODUCT PORTFOLIO
TABLE 91. MICROBIOME INSIGHTS: NET SALES
TABLE 92. MICROBIOME INSIGHTS: KEY STRATERGIES
TABLE 93.  CLINICAL MICROBIOMICS: KEY EXECUTIVES
TABLE 94.  CLINICAL MICROBIOMICS: COMPANY SNAPSHOT
TABLE 95.  CLINICAL MICROBIOMICS: OPERATING SEGMENTS
TABLE 96.  CLINICAL MICROBIOMICS: PRODUCT PORTFOLIO
TABLE 97.  CLINICAL MICROBIOMICS: NET SALES
TABLE 98.  CLINICAL MICROBIOMICS: KEY STRATERGIES
TABLE 99. BASECLEAR BV: KEY EXECUTIVES
TABLE 100. BASECLEAR BV: COMPANY SNAPSHOT
TABLE 101. BASECLEAR BV: OPERATING SEGMENTS
TABLE 102. BASECLEAR BV: PRODUCT PORTFOLIO
TABLE 103. BASECLEAR BV: NET SALES
TABLE 104. BASECLEAR BV: KEY STRATERGIES
TABLE 105. COSMOSID: KEY EXECUTIVES
TABLE 106. COSMOSID: COMPANY SNAPSHOT
TABLE 107. COSMOSID: OPERATING SEGMENTS
TABLE 108. COSMOSID: PRODUCT PORTFOLIO
TABLE 109. COSMOSID: NET SALES
TABLE 110. COSMOSID: KEY STRATERGIES
TABLE 111.  NOVOGENE CO., LTD. : KEY EXECUTIVES
TABLE 112.  NOVOGENE CO., LTD. : COMPANY SNAPSHOT
TABLE 113.  NOVOGENE CO., LTD. : OPERATING SEGMENTS
TABLE 114.  NOVOGENE CO., LTD. : PRODUCT PORTFOLIO
TABLE 115.  NOVOGENE CO., LTD. : NET SALES
TABLE 116.  NOVOGENE CO., LTD. : KEY STRATERGIES
TABLE 117. ZYMO RESEARCH CORPORATION: KEY EXECUTIVES
TABLE 118. ZYMO RESEARCH CORPORATION: COMPANY SNAPSHOT
TABLE 119. ZYMO RESEARCH CORPORATION: OPERATING SEGMENTS
TABLE 120. ZYMO RESEARCH CORPORATION: PRODUCT PORTFOLIO
TABLE 121. ZYMO RESEARCH CORPORATION: NET SALES
TABLE 122. ZYMO RESEARCH CORPORATION: KEY STRATERGIES
TABLE 123. RESPHERA BIOSCIENCES, LLC: KEY EXECUTIVES
TABLE 124. RESPHERA BIOSCIENCES, LLC: COMPANY SNAPSHOT
TABLE 125. RESPHERA BIOSCIENCES, LLC: OPERATING SEGMENTS
TABLE 126. RESPHERA BIOSCIENCES, LLC: PRODUCT PORTFOLIO
TABLE 127. RESPHERA BIOSCIENCES, LLC: NET SALES
TABLE 128. RESPHERA BIOSCIENCES, LLC: KEY STRATERGIES
TABLE 129. ORASURE TECHNOLOGIES (DIVERSIGEN): KEY EXECUTIVES
TABLE 130. ORASURE TECHNOLOGIES (DIVERSIGEN): COMPANY SNAPSHOT
TABLE 131. ORASURE TECHNOLOGIES (DIVERSIGEN): OPERATING SEGMENTS
TABLE 132. ORASURE TECHNOLOGIES (DIVERSIGEN): PRODUCT PORTFOLIO
TABLE 133. ORASURE TECHNOLOGIES (DIVERSIGEN): NET SALES
TABLE 134. ORASURE TECHNOLOGIES (DIVERSIGEN): KEY STRATERGIES
TABLE 135. MOLECULAR RESEARCH LP: KEY EXECUTIVES
TABLE 136. MOLECULAR RESEARCH LP: COMPANY SNAPSHOT
TABLE 137. MOLECULAR RESEARCH LP: OPERATING SEGMENTS
TABLE 138. MOLECULAR RESEARCH LP: PRODUCT PORTFOLIO
TABLE 139. MOLECULAR RESEARCH LP: NET SALES
TABLE 140. MOLECULAR RESEARCH LP: KEY STRATERGIES
TABLE 141. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY EXECUTIVES
TABLE 142. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 143. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: OPERATING SEGMENTS
TABLE 144. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCT PORTFOLIO
TABLE 145. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: NET SALES
TABLE 146. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 医療機器洗浄のグローバル市場（2021-2031）：クリティカル、セミクリティカル、ノンクリティカル
  • 組織内照射療法のグローバル市場（2021〜2031）：シード、アプリケータ・アフターローダー、電気式組織内照射療法
  • 衝撃波治療のグローバル市場（2021〜2031）：電気油圧技術、圧電技術、ラジアル技術、電磁衝撃波
  • 圧迫療法のグローバル市場（2021-2031）：静的圧縮療法、動的圧縮療法
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23MA110 )"マイクロバイオームシーケンスのグローバル市場（2021〜2031）：ショットガンシーケンス、RNAシーケンス、標的遺伝子シーケンス、全ゲノムシーケンス、その他" (英文：Microbiome Sequencing Market By Technique (Shotgun sequencing, RNA sequencing, Targeted gene sequencing, Whole genome sequencing, Others), By Research (Outsourced, Internal), By End user (Pharmaceutical and biotechnological companies, Academic institutes and research centers): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。